

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline metabolic process (GO:0006560) | 8.31017007 |
| 2 | transcription from mitochondrial promoter (GO:0006390) | 7.87294542 |
| 3 | DNA deamination (GO:0045006) | 7.47868226 |
| 4 | replication fork processing (GO:0031297) | 7.17039110 |
| 5 | positive regulation of protein homooligomerization (GO:0032464) | 7.14129886 |
| 6 | embryonic process involved in female pregnancy (GO:0060136) | 6.99277945 |
| 7 | regulation of integrin activation (GO:0033623) | 6.31588458 |
| 8 | oxidative demethylation (GO:0070989) | 5.93990866 |
| 9 | regulation of protein homooligomerization (GO:0032462) | 5.79974024 |
| 10 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.76615016 |
| 11 | cellular response to zinc ion (GO:0071294) | 5.38013548 |
| 12 | poly(A)+ mRNA export from nucleus (GO:0016973) | 5.27060366 |
| 13 | mitochondrial DNA metabolic process (GO:0032042) | 4.91282452 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.90449868 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84451535 |
| 16 | viral mRNA export from host cell nucleus (GO:0046784) | 4.83879586 |
| 17 | establishment of apical/basal cell polarity (GO:0035089) | 4.77639124 |
| 18 | cellular response to ATP (GO:0071318) | 4.70724080 |
| 19 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.70561581 |
| 20 | DNA strand renaturation (GO:0000733) | 4.69055540 |
| 21 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.59295072 |
| 22 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.59295072 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.53960620 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 4.34596785 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 4.34596785 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.34596785 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.34596785 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.34596785 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.34596785 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 4.28837353 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.27710923 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.26453067 |
| 33 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.26406160 |
| 34 | positive regulation of protein oligomerization (GO:0032461) | 4.22799904 |
| 35 | response to peptidoglycan (GO:0032494) | 4.18014410 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13703663 |
| 37 | embryonic placenta development (GO:0001892) | 4.13020411 |
| 38 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.12408412 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99233123 |
| 40 | establishment of monopolar cell polarity (GO:0061162) | 3.96517445 |
| 41 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.96517445 |
| 42 | DNA integration (GO:0015074) | 3.95670771 |
| 43 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.95142709 |
| 44 | positive regulation of developmental pigmentation (GO:0048087) | 3.93569241 |
| 45 | formation of translation preinitiation complex (GO:0001731) | 3.92780563 |
| 46 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.91504064 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.88567911 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88567911 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.87627102 |
| 50 | mRNA cleavage (GO:0006379) | 3.82893868 |
| 51 | base-excision repair (GO:0006284) | 3.81801840 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.81460554 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76465966 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75969334 |
| 55 | negative regulation of cell cycle arrest (GO:0071157) | 3.73999815 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.72835965 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.72302434 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71652709 |
| 59 | mitochondrial RNA metabolic process (GO:0000959) | 3.69795832 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68686435 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 3.67506539 |
| 62 | base-excision repair, AP site formation (GO:0006285) | 3.66573458 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66355477 |
| 64 | microglial cell activation (GO:0001774) | 3.64154303 |
| 65 | cellular extravasation (GO:0045123) | 3.63204335 |
| 66 | detection of other organism (GO:0098543) | 3.62520626 |
| 67 | regulation of protein oligomerization (GO:0032459) | 3.59566649 |
| 68 | B cell mediated immunity (GO:0019724) | 3.54987531 |
| 69 | detection of bacterium (GO:0016045) | 3.49784726 |
| 70 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.49400490 |
| 71 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.48870737 |
| 72 | mitotic G1/S transition checkpoint (GO:0044819) | 3.48303539 |
| 73 | GDP-mannose metabolic process (GO:0019673) | 3.45756253 |
| 74 | non-recombinational repair (GO:0000726) | 3.45330511 |
| 75 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.45330511 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.44457859 |
| 77 | alkaloid metabolic process (GO:0009820) | 3.42967483 |
| 78 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42936419 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.42857223 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 3.40819461 |
| 81 | negative regulation of protein oligomerization (GO:0032460) | 3.37246938 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.31800337 |
| 83 | telomere maintenance via recombination (GO:0000722) | 3.30823875 |
| 84 | membrane invagination (GO:0010324) | 3.29719727 |
| 85 | neutrophil activation (GO:0042119) | 3.29306932 |
| 86 | G1 DNA damage checkpoint (GO:0044783) | 3.28923046 |
| 87 | meiotic chromosome segregation (GO:0045132) | 3.28909944 |
| 88 | regulation of podosome assembly (GO:0071801) | 3.28323864 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28119870 |
| 90 | glial cell migration (GO:0008347) | 3.27367245 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.27319980 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 3.27319980 |
| 93 | respiratory burst (GO:0045730) | 3.25644315 |
| 94 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.23627487 |
| 95 | regulation of mast cell activation (GO:0033003) | 3.20734763 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20554689 |
| 97 | DNA ligation (GO:0006266) | 3.20528487 |
| 98 | macrophage activation (GO:0042116) | 3.18954578 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18278312 |
| 100 | positive regulation by host of viral transcription (GO:0043923) | 3.18140016 |
| 101 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.15861351 |
| 102 | granulocyte activation (GO:0036230) | 3.14326567 |
| 103 | regulation of mitochondrial depolarization (GO:0051900) | 3.13065032 |
| 104 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.11499780 |
| 105 | response to host immune response (GO:0052572) | 3.11349633 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.11349633 |
| 107 | face development (GO:0060324) | 3.10015759 |
| 108 | positive regulation of DNA repair (GO:0045739) | 3.09425338 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.08956510 |
| 110 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08643002 |
| 111 | DNA demethylation (GO:0080111) | 3.06817730 |
| 112 | regulation of B cell differentiation (GO:0045577) | 3.06581334 |
| 113 | maturation of 5.8S rRNA (GO:0000460) | 3.04470715 |
| 114 | DNA topological change (GO:0006265) | 3.03611771 |
| 115 | DNA double-strand break processing (GO:0000729) | 3.02827843 |
| 116 | kinetochore assembly (GO:0051382) | 3.01878353 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01154910 |
| 118 | positive regulation of receptor recycling (GO:0001921) | 2.96065048 |
| 119 | anatomical structure regression (GO:0060033) | 2.95407524 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95308575 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94296842 |
| 122 | mitochondrial DNA replication (GO:0006264) | 2.93445408 |
| 123 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.93261162 |
| 124 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.93037713 |
| 125 | pentose metabolic process (GO:0019321) | 2.92327343 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91984725 |
| 127 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.91786361 |
| 128 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.91786361 |
| 129 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.91786361 |
| 130 | intestinal cholesterol absorption (GO:0030299) | 2.91192260 |
| 131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90552301 |
| 132 | negative regulation of phagocytosis (GO:0050765) | 2.89582356 |
| 133 | B cell receptor signaling pathway (GO:0050853) | 2.89514189 |
| 134 | regulation of mononuclear cell migration (GO:0071675) | 2.87929809 |
| 135 | amino sugar catabolic process (GO:0046348) | 2.87262665 |
| 136 | regulation of macrophage chemotaxis (GO:0010758) | 2.85725425 |
| 137 | nuclear envelope reassembly (GO:0031468) | 2.84927305 |
| 138 | mitotic nuclear envelope reassembly (GO:0007084) | 2.84927305 |
| 139 | detection of molecule of bacterial origin (GO:0032490) | 2.84705497 |
| 140 | apoptotic process involved in morphogenesis (GO:0060561) | 2.84383588 |
| 141 | negative regulation of heart rate (GO:0010459) | 2.83457099 |
| 142 | regulation of translational fidelity (GO:0006450) | 2.83070000 |
| 143 | defense response to protozoan (GO:0042832) | 2.82982410 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.80636123 |
| 145 | dosage compensation (GO:0007549) | 2.80118512 |
| 146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79869900 |
| 147 | activation of Rac GTPase activity (GO:0032863) | 2.78129765 |
| 148 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.78001839 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 2.77878393 |
| 150 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.76502627 |
| 151 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.75795847 |
| 152 | detection of biotic stimulus (GO:0009595) | 2.75733189 |
| 153 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75676182 |
| 154 | response to interferon-beta (GO:0035456) | 2.73842881 |
| 155 | embryonic camera-type eye development (GO:0031076) | 2.73789439 |
| 156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73605492 |
| 157 | DNA strand elongation (GO:0022616) | 2.73241406 |
| 158 | negative regulation of Ras GTPase activity (GO:0034261) | 2.72956371 |
| 159 | leukocyte degranulation (GO:0043299) | 2.71727422 |
| 160 | termination of RNA polymerase II transcription (GO:0006369) | 2.71530809 |
| 161 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71219045 |
| 162 | response to host (GO:0075136) | 2.71144903 |
| 163 | response to host defenses (GO:0052200) | 2.71144903 |
| 164 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71144903 |
| 165 | hypotonic response (GO:0006971) | 2.71089660 |
| 166 | cellular response to type I interferon (GO:0071357) | 2.69989733 |
| 167 | type I interferon signaling pathway (GO:0060337) | 2.69989733 |
| 168 | regulation of B cell apoptotic process (GO:0002902) | 2.69781250 |
| 169 | response to type I interferon (GO:0034340) | 2.69737295 |
| 170 | negative regulation of viral release from host cell (GO:1902187) | 2.69387267 |
| 171 | negative regulation of response to food (GO:0032096) | 2.68986121 |
| 172 | negative regulation of appetite (GO:0032099) | 2.68986121 |
| 173 | N-acetylneuraminate metabolic process (GO:0006054) | 2.68779088 |
| 174 | mitotic cell cycle arrest (GO:0071850) | 2.68682512 |
| 175 | regulation of germinal center formation (GO:0002634) | 2.67942689 |
| 176 | response to xenobiotic stimulus (GO:0009410) | 2.66563678 |
| 177 | positive regulation of defense response to virus by host (GO:0002230) | 2.63401962 |
| 178 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.63201032 |
| 179 | response to protozoan (GO:0001562) | 2.62606187 |
| 180 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62372539 |
| 181 | positive regulation of interferon-alpha production (GO:0032727) | 2.62344562 |
| 182 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62133797 |
| 183 | negative regulation of innate immune response (GO:0045824) | 2.61853214 |
| 184 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60592401 |
| 185 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.58600842 |
| 186 | negative regulation of interleukin-6 production (GO:0032715) | 2.57392754 |
| 187 | neutrophil mediated immunity (GO:0002446) | 2.56932256 |
| 188 | regulation of interferon-alpha production (GO:0032647) | 2.55895449 |
| 189 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55132561 |
| 190 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54395444 |
| 191 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.54178934 |
| 192 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.54178934 |
| 193 | negative regulation of T cell mediated immunity (GO:0002710) | 2.54170842 |
| 194 | positive regulation of type 2 immune response (GO:0002830) | 2.52419850 |
| 195 | T-helper 1 type immune response (GO:0042088) | 2.52252686 |
| 196 | leukocyte aggregation (GO:0070486) | 2.52079087 |
| 197 | positive thymic T cell selection (GO:0045059) | 2.51476986 |
| 198 | mast cell activation (GO:0045576) | 2.50810748 |
| 199 | proline biosynthetic process (GO:0006561) | 10.5677247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.38304114 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.24744971 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06226106 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02114110 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80933180 |
| 6 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.78022555 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.70561359 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.70561359 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.70561359 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65075644 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60061392 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.59738139 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58139235 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38389958 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29011876 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27998093 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27402960 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23326173 |
| 19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.18183152 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.16443046 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14307187 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14002595 |
| 23 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 2.09788915 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09759025 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05917375 |
| 26 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.99845057 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97362411 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97098919 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.95953297 |
| 30 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95195802 |
| 31 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92038997 |
| 32 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90907764 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86608272 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.85020912 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83302420 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82830073 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82115641 |
| 38 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.81232494 |
| 39 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.80468074 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79769480 |
| 41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78837179 |
| 42 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.77365023 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76429046 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76336215 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.75598702 |
| 46 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.73816905 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70147966 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68114527 |
| 49 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.67421636 |
| 50 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.66348186 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65327565 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.60781564 |
| 53 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.60105775 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59001612 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58845809 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58050911 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57968087 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57196601 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56159170 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55650598 |
| 61 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.55187998 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.54471117 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50327742 |
| 64 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48503870 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48249067 |
| 66 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48199634 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47011648 |
| 68 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46769692 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45922508 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44734110 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41566969 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40670113 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36709852 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36208731 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36014070 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35174473 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35146854 |
| 78 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.31792975 |
| 79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.31369109 |
| 80 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30835794 |
| 81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30230263 |
| 82 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28881055 |
| 83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28863243 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28312911 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28101528 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28098413 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.27100337 |
| 88 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26958464 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26776509 |
| 90 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26693532 |
| 91 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.26515349 |
| 92 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.26211058 |
| 93 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.25572125 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25023010 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.24884304 |
| 96 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24544512 |
| 97 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.23929082 |
| 98 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22657980 |
| 99 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20443064 |
| 100 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20200480 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20095732 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19966635 |
| 103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.19609297 |
| 104 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17544088 |
| 105 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16259326 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15980426 |
| 107 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.15807343 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.15283462 |
| 109 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.14807828 |
| 110 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.14700697 |
| 111 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14378179 |
| 112 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13888847 |
| 113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13271132 |
| 114 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.13176062 |
| 115 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12671473 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11990596 |
| 117 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11605266 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11361272 |
| 119 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.10870820 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10701818 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10592209 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10100192 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09844340 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09363075 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08522740 |
| 126 | P300_27268052_Chip-Seq_Bcells_Human | 1.08411991 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07509890 |
| 128 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07368500 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07112165 |
| 130 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06673136 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06634333 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06128730 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 1.06010987 |
| 134 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05436849 |
| 135 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.04847394 |
| 136 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04682799 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03901852 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03434588 |
| 139 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03339935 |
| 140 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03083908 |
| 141 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.02868768 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02522139 |
| 143 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02389089 |
| 144 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01951672 |
| 145 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01728938 |
| 146 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.01480034 |
| 147 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00746866 |
| 148 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.00684385 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00442767 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00355141 |
| 151 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99274168 |
| 152 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99111619 |
| 153 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98943719 |
| 154 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98562784 |
| 155 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97974287 |
| 156 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.97969151 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91244667 |
| 158 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90744297 |
| 159 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89716165 |
| 160 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89192659 |
| 161 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88583715 |
| 162 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88084543 |
| 163 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83319260 |
| 164 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82759721 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81580013 |
| 166 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81228616 |
| 167 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79800326 |
| 168 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79567875 |
| 169 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79068621 |
| 170 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.78636266 |
| 171 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77775945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.61431404 |
| 2 | MP0005171_absent_coat_pigmentation | 4.38977296 |
| 3 | MP0009278_abnormal_bone_marrow | 4.32057966 |
| 4 | MP0002009_preneoplasia | 3.07925150 |
| 5 | MP0005671_abnormal_response_to | 2.85911303 |
| 6 | MP0010030_abnormal_orbit_morphology | 2.61663202 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.55253849 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.54930512 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.54930512 |
| 10 | MP0008995_early_reproductive_senescence | 2.42781850 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.32503805 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.28407756 |
| 13 | MP0001819_abnormal_immune_cell | 2.25612112 |
| 14 | MP0004233_abnormal_muscle_weight | 2.24747712 |
| 15 | MP0005365_abnormal_bile_salt | 2.22262048 |
| 16 | MP0003303_peritoneal_inflammation | 2.18604183 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.17857971 |
| 18 | MP0006082_CNS_inflammation | 2.12493202 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.12407354 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.05574525 |
| 21 | MP0000685_abnormal_immune_system | 1.98180277 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.94658624 |
| 23 | MP0003786_premature_aging | 1.93956300 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.85927421 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.83889291 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.71774801 |
| 27 | MP0009764_decreased_sensitivity_to | 1.65275625 |
| 28 | MP0005310_abnormal_salivary_gland | 1.63130506 |
| 29 | MP0008469_abnormal_protein_level | 1.62955962 |
| 30 | MP0008058_abnormal_DNA_repair | 1.61913960 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.60093736 |
| 32 | MP0003890_abnormal_embryonic-extraembry | 1.59846220 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.59559300 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.59050699 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.57924210 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.56011347 |
| 37 | MP0000371_diluted_coat_color | 1.50995537 |
| 38 | MP0004133_heterotaxia | 1.50787448 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.49435535 |
| 40 | MP0001853_heart_inflammation | 1.48751395 |
| 41 | MP0000490_abnormal_crypts_of | 1.46428119 |
| 42 | MP0009840_abnormal_foam_cell | 1.43342848 |
| 43 | MP0001873_stomach_inflammation | 1.43026491 |
| 44 | MP0000343_altered_response_to | 1.42754028 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.41906801 |
| 46 | MP0002405_respiratory_system_inflammati | 1.37799267 |
| 47 | MP0002132_abnormal_respiratory_system | 1.34252716 |
| 48 | MP0004947_skin_inflammation | 1.32489311 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.27897096 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.27782068 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.27288049 |
| 52 | MP0000470_abnormal_stomach_morphology | 1.24452956 |
| 53 | MP0003195_calcinosis | 1.21461331 |
| 54 | MP0000639_abnormal_adrenal_gland | 1.18771607 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.16666238 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.16196514 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.16033028 |
| 58 | MP0003436_decreased_susceptibility_to | 1.15258295 |
| 59 | MP0001293_anophthalmia | 1.14123973 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.10781168 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.10594292 |
| 62 | MP0000604_amyloidosis | 1.09942951 |
| 63 | MP0003283_abnormal_digestive_organ | 1.09557981 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.09136252 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.08627880 |
| 66 | MP0005025_abnormal_response_to | 1.07862439 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.07477285 |
| 68 | MP0002282_abnormal_trachea_morphology | 1.07123166 |
| 69 | MP0002249_abnormal_larynx_morphology | 1.06292825 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.06047808 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.05838737 |
| 72 | MP0000858_altered_metastatic_potential | 1.05623693 |
| 73 | MP0000579_abnormal_nail_morphology | 1.04901295 |
| 74 | MP0003828_pulmonary_edema | 1.04464150 |
| 75 | MP0002933_joint_inflammation | 1.03331332 |
| 76 | MP0004883_abnormal_blood_vessel | 1.02355339 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.02125671 |
| 78 | MP0009785_altered_susceptibility_to | 1.01637963 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.01427228 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 1.00838764 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 1.00781478 |
| 82 | MP0003186_abnormal_redox_activity | 1.00659853 |
| 83 | MP0003866_abnormal_defecation | 1.00552789 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 0.99457788 |
| 85 | MP0002006_tumorigenesis | 0.97559825 |
| 86 | MP0003111_abnormal_nucleus_morphology | 0.97020122 |
| 87 | MP0002254_reproductive_system_inflammat | 0.96921802 |
| 88 | MP0005166_decreased_susceptibility_to | 0.96726025 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.96042911 |
| 90 | MP0005164_abnormal_response_to | 0.96004013 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 0.95503204 |
| 92 | MP0001851_eye_inflammation | 0.94705400 |
| 93 | MP0003448_altered_tumor_morphology | 0.94644250 |
| 94 | MP0001663_abnormal_digestive_system | 0.94382841 |
| 95 | MP0003718_maternal_effect | 0.94366582 |
| 96 | MP0005266_abnormal_metabolism | 0.93220915 |
| 97 | MP0003075_altered_response_to | 0.91623322 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.90946728 |
| 99 | MP0009763_increased_sensitivity_to | 0.90594372 |
| 100 | MP0008004_abnormal_stomach_pH | 0.90053391 |
| 101 | MP0009115_abnormal_fat_cell | 0.89014173 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.88690699 |
| 103 | MP0008260_abnormal_autophagy | 0.88394026 |
| 104 | MP0005390_skeleton_phenotype | 0.88141537 |
| 105 | MP0002398_abnormal_bone_marrow | 0.88124788 |
| 106 | MP0001764_abnormal_homeostasis | 0.87451182 |
| 107 | MP0005360_urolithiasis | 0.87439130 |
| 108 | MP0008932_abnormal_embryonic_tissue | 0.86238793 |
| 109 | MP0003724_increased_susceptibility_to | 0.85733784 |
| 110 | MP0002075_abnormal_coat/hair_pigmentati | 0.84133458 |
| 111 | MP0001800_abnormal_humoral_immune | 0.82952732 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.82481846 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.82317880 |
| 114 | MP0002723_abnormal_immune_serum | 0.81882350 |
| 115 | MP0001697_abnormal_embryo_size | 0.81820564 |
| 116 | MP0001790_abnormal_immune_system | 0.81666113 |
| 117 | MP0005387_immune_system_phenotype | 0.81666113 |
| 118 | MP0004510_myositis | 0.81656633 |
| 119 | MP0010307_abnormal_tumor_latency | 0.81603655 |
| 120 | MP0000609_abnormal_liver_physiology | 0.80699007 |
| 121 | MP0001186_pigmentation_phenotype | 0.79844589 |
| 122 | MP0000716_abnormal_immune_system | 0.78922266 |
| 123 | MP0002419_abnormal_innate_immunity | 0.78894658 |
| 124 | MP0002452_abnormal_antigen_presenting | 0.78726856 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.78557170 |
| 126 | MP0003077_abnormal_cell_cycle | 0.78328247 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.77904943 |
| 128 | MP0003119_abnormal_digestive_system | 0.76382680 |
| 129 | MP0005451_abnormal_body_composition | 0.75925314 |
| 130 | MP0004381_abnormal_hair_follicle | 0.75501347 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.74608745 |
| 132 | MP0003795_abnormal_bone_structure | 0.74323351 |
| 133 | MP0002722_abnormal_immune_system | 0.74242456 |
| 134 | MP0000313_abnormal_cell_death | 0.73231822 |
| 135 | MP0000598_abnormal_liver_morphology | 0.72924674 |
| 136 | MP0005332_abnormal_amino_acid | 0.72827451 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.72646738 |
| 138 | MP0002429_abnormal_blood_cell | 0.71896223 |
| 139 | MP0003045_fibrosis | 0.71863189 |
| 140 | MP0002060_abnormal_skin_morphology | 0.71743608 |
| 141 | MP0002269_muscular_atrophy | 0.71613448 |
| 142 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70961700 |
| 143 | MP0000462_abnormal_digestive_system | 0.70250560 |
| 144 | MP0005165_increased_susceptibility_to | 0.70114749 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.69765882 |
| 146 | MP0004808_abnormal_hematopoietic_stem | 0.69545073 |
| 147 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68959955 |
| 148 | MP0006054_spinal_hemorrhage | 0.67937867 |
| 149 | MP0005084_abnormal_gallbladder_morpholo | 0.67261331 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.66265864 |
| 151 | MP0003690_abnormal_glial_cell | 0.66170469 |
| 152 | MP0001542_abnormal_bone_strength | 0.64859797 |
| 153 | MP0000249_abnormal_blood_vessel | 0.64755087 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.61434772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 5.79705094 |
| 2 | Pustule (HP:0200039) | 5.63337280 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.34742462 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.34742462 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.34742462 |
| 6 | Poikiloderma (HP:0001029) | 4.96194442 |
| 7 | Rectovaginal fistula (HP:0000143) | 4.64578870 |
| 8 | Rectal fistula (HP:0100590) | 4.64578870 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.57505534 |
| 10 | Rib fusion (HP:0000902) | 4.57132067 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.54066878 |
| 12 | Stomatitis (HP:0010280) | 4.38119519 |
| 13 | Alopecia of scalp (HP:0002293) | 4.33128138 |
| 14 | Myositis (HP:0100614) | 4.28558765 |
| 15 | Vaginal fistula (HP:0004320) | 4.27038798 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.22708058 |
| 17 | Intestinal fistula (HP:0100819) | 4.16152628 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 4.14182247 |
| 19 | Concave nail (HP:0001598) | 4.13417307 |
| 20 | Turricephaly (HP:0000262) | 4.12519464 |
| 21 | Eczematoid dermatitis (HP:0000976) | 4.08926312 |
| 22 | Facial hemangioma (HP:0000329) | 4.08686559 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.03810584 |
| 24 | Mucopolysacchariduria (HP:0008155) | 4.03810584 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 4.03368062 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.99868596 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.93333356 |
| 28 | Abnormality of male internal genitalia (HP:0000022) | 3.80998767 |
| 29 | Orchitis (HP:0100796) | 3.79174152 |
| 30 | Albinism (HP:0001022) | 3.78155367 |
| 31 | Dysostosis multiplex (HP:0000943) | 3.76834115 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.76518991 |
| 33 | Tongue fasciculations (HP:0001308) | 3.74280387 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.73019427 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.73019427 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.73019427 |
| 37 | Intestinal atresia (HP:0011100) | 3.66008043 |
| 38 | Ulnar bowing (HP:0003031) | 3.65618980 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 3.59003864 |
| 40 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.56377596 |
| 41 | Annular pancreas (HP:0001734) | 3.55694015 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 3.50024900 |
| 43 | Optic neuritis (HP:0100653) | 3.50024900 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46542926 |
| 45 | Recurrent fungal infections (HP:0002841) | 3.45000223 |
| 46 | Abnormal hemoglobin (HP:0011902) | 3.43579839 |
| 47 | Muscle fibrillation (HP:0010546) | 3.29913652 |
| 48 | Meningitis (HP:0001287) | 3.29531027 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27896820 |
| 50 | Obstructive lung disease (HP:0006536) | 3.27896820 |
| 51 | Coronal craniosynostosis (HP:0004440) | 3.25189246 |
| 52 | Recurrent skin infections (HP:0001581) | 3.17550983 |
| 53 | Anteriorly placed anus (HP:0001545) | 3.16818887 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13625074 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13625074 |
| 56 | Premature skin wrinkling (HP:0100678) | 3.13572824 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12030500 |
| 58 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.04879826 |
| 59 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.04781149 |
| 60 | Vertebral hypoplasia (HP:0008417) | 3.04781149 |
| 61 | Male infertility (HP:0003251) | 3.03048131 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.97609800 |
| 63 | Large for gestational age (HP:0001520) | 2.96659520 |
| 64 | IgA deficiency (HP:0002720) | 2.92053117 |
| 65 | Orthostatic hypotension (HP:0001278) | 2.90079136 |
| 66 | Joint stiffness (HP:0001387) | 2.87326497 |
| 67 | Hypokinesia (HP:0002375) | 2.84921768 |
| 68 | Premature graying of hair (HP:0002216) | 2.83360903 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.83226541 |
| 70 | Lower limb hyperreflexia (HP:0002395) | 2.80451833 |
| 71 | Loss of speech (HP:0002371) | 2.79999241 |
| 72 | Encephalitis (HP:0002383) | 2.77947584 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 2.77506083 |
| 74 | Clumsiness (HP:0002312) | 2.77479573 |
| 75 | Hemoptysis (HP:0002105) | 2.76653917 |
| 76 | Short humerus (HP:0005792) | 2.74593619 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.74089891 |
| 78 | Dysautonomia (HP:0002459) | 2.72856993 |
| 79 | Petechiae (HP:0000967) | 2.70800994 |
| 80 | Vasculitis (HP:0002633) | 2.69687798 |
| 81 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.67792804 |
| 82 | Alacrima (HP:0000522) | 2.63280784 |
| 83 | Diaphragmatic weakness (HP:0009113) | 2.62135542 |
| 84 | Squamous cell carcinoma (HP:0002860) | 2.60036122 |
| 85 | Absent radius (HP:0003974) | 2.59384872 |
| 86 | Hematochezia (HP:0002573) | 2.58570290 |
| 87 | Hypochromic anemia (HP:0001931) | 2.58122905 |
| 88 | Absent thumb (HP:0009777) | 2.55153131 |
| 89 | Exertional dyspnea (HP:0002875) | 2.54883990 |
| 90 | Amyloidosis (HP:0011034) | 2.49928706 |
| 91 | Polycythemia (HP:0001901) | 2.49530626 |
| 92 | Urticaria (HP:0001025) | 2.48066995 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.47975506 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.47012825 |
| 95 | Bifid uvula (HP:0000193) | 2.46077387 |
| 96 | Broad alveolar ridges (HP:0000187) | 2.46035275 |
| 97 | Abnormality of the prostate (HP:0008775) | 2.45138401 |
| 98 | Recurrent viral infections (HP:0004429) | 2.42321904 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.41124407 |
| 100 | Growth hormone excess (HP:0000845) | 2.40959503 |
| 101 | Aplasia involving forearm bones (HP:0009822) | 2.40650739 |
| 102 | Absent forearm bone (HP:0003953) | 2.40650739 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.40339310 |
| 104 | Aplasia of the musculature (HP:0100854) | 2.38880886 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 2.36181664 |
| 106 | Mutism (HP:0002300) | 2.35803454 |
| 107 | Cheilitis (HP:0100825) | 2.34962552 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34227095 |
| 109 | Short chin (HP:0000331) | 2.31124096 |
| 110 | Capillary hemangiomas (HP:0005306) | 2.30528558 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.30182074 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 2.29056711 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25873795 |
| 114 | Recurrent bronchitis (HP:0002837) | 2.25755174 |
| 115 | Hypotrichosis (HP:0001006) | 2.25082370 |
| 116 | Amelogenesis imperfecta (HP:0000705) | 2.24992424 |
| 117 | Increased serum ferritin (HP:0003281) | 2.24161368 |
| 118 | Chest pain (HP:0100749) | 2.23167858 |
| 119 | Opisthotonus (HP:0002179) | 2.21817533 |
| 120 | Bulbar palsy (HP:0001283) | 2.19119673 |
| 121 | Myocardial infarction (HP:0001658) | 2.19096286 |
| 122 | Congenital hip dislocation (HP:0001374) | 2.18199361 |
| 123 | Granulocytopenia (HP:0001913) | 2.17714693 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 2.17661258 |
| 125 | Hypobetalipoproteinemia (HP:0003563) | 2.16904665 |
| 126 | Leukocytosis (HP:0001974) | 2.16152221 |
| 127 | Increased IgE level (HP:0003212) | 2.16016118 |
| 128 | Abnormality of T cells (HP:0002843) | 2.15012830 |
| 129 | Cellulitis (HP:0100658) | 2.15012683 |
| 130 | Inflammation of the large intestine (HP:0002037) | 2.14378502 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 2.13938364 |
| 132 | Gingivitis (HP:0000230) | 2.13794508 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 2.12949243 |
| 134 | T lymphocytopenia (HP:0005403) | 2.11883532 |
| 135 | Epistaxis (HP:0000421) | 2.11358854 |
| 136 | Abnormality of T cell number (HP:0011839) | 2.10874819 |
| 137 | Redundant skin (HP:0001582) | 2.10182979 |
| 138 | Muscle fiber atrophy (HP:0100295) | 2.10144777 |
| 139 | Polyneuropathy (HP:0001271) | 2.09015407 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 2.08280390 |
| 141 | Abnormality of the aortic arch (HP:0012303) | 2.07780869 |
| 142 | Bowed forearm bones (HP:0003956) | 2.07300255 |
| 143 | Bowing of the arm (HP:0006488) | 2.07300255 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 2.06691346 |
| 145 | Prolonged bleeding time (HP:0003010) | 2.06664455 |
| 146 | Eosinophilia (HP:0001880) | 2.06340205 |
| 147 | Abnormality of B cell number (HP:0010975) | 2.05966137 |
| 148 | Thrombocytosis (HP:0001894) | 2.05441532 |
| 149 | Gastrointestinal inflammation (HP:0004386) | 2.04918177 |
| 150 | Hypotelorism (HP:0000601) | 2.03812669 |
| 151 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02884977 |
| 152 | Pulmonary fibrosis (HP:0002206) | 2.02774518 |
| 153 | Episodic fever (HP:0001954) | 2.02642503 |
| 154 | Autoimmune hemolytic anemia (HP:0001890) | 2.02165080 |
| 155 | Recurrent pneumonia (HP:0006532) | 2.01216257 |
| 156 | Osteomyelitis (HP:0002754) | 2.00362445 |
| 157 | Chronic sinusitis (HP:0011109) | 1.99866826 |
| 158 | Abnormality of the pleura (HP:0002103) | 1.99540689 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.99020701 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98373501 |
| 161 | Disinhibition (HP:0000734) | 1.98144014 |
| 162 | Selective tooth agenesis (HP:0001592) | 1.96481003 |
| 163 | IgG deficiency (HP:0004315) | 1.96419973 |
| 164 | Skin rash (HP:0000988) | 1.95267834 |
| 165 | Decreased lacrimation (HP:0000633) | 1.94675019 |
| 166 | Basal cell carcinoma (HP:0002671) | 1.94612124 |
| 167 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.94462095 |
| 168 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.94462095 |
| 169 | Generalized amyotrophy (HP:0003700) | 1.93743149 |
| 170 | Amniotic constriction ring (HP:0009775) | 1.92187255 |
| 171 | Abnormality of placental membranes (HP:0011409) | 1.92187255 |
| 172 | Purpura (HP:0000979) | 1.91839600 |
| 173 | Gastrointestinal atresia (HP:0002589) | 1.91513982 |
| 174 | Abnormality of the periventricular white matter (HP:0002518) | 1.90794553 |
| 175 | Popliteal pterygium (HP:0009756) | 1.90483477 |
| 176 | Cone-rod dystrophy (HP:0000548) | 1.90339437 |
| 177 | Gangrene (HP:0100758) | 1.90305226 |
| 178 | Prostate neoplasm (HP:0100787) | 1.89955755 |
| 179 | Colitis (HP:0002583) | 1.88881433 |
| 180 | Increased number of teeth (HP:0011069) | 1.87887308 |
| 181 | Diminished movement (HP:0002374) | 1.87875678 |
| 182 | Choanal stenosis (HP:0000452) | 1.87452889 |
| 183 | Restrictive lung disease (HP:0002091) | 1.87399941 |
| 184 | Anorexia (HP:0002039) | 1.86825989 |
| 185 | Premature loss of primary teeth (HP:0006323) | 1.86232699 |
| 186 | Pulmonary embolism (HP:0002204) | 1.85892582 |
| 187 | Gingival bleeding (HP:0000225) | 1.85005793 |
| 188 | Hamartoma (HP:0010566) | 1.82834590 |
| 189 | Acute lymphatic leukemia (HP:0006721) | 1.82540267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.81421650 |
| 2 | ICK | 5.40163069 |
| 3 | DDR2 | 4.52783360 |
| 4 | MAP3K6 | 4.46147295 |
| 5 | PINK1 | 3.35304695 |
| 6 | MAP3K11 | 3.21220340 |
| 7 | MATK | 3.18036333 |
| 8 | PIM2 | 3.12101078 |
| 9 | FGR | 2.91770742 |
| 10 | RIPK4 | 2.74782729 |
| 11 | CSK | 2.53976095 |
| 12 | YES1 | 2.46816976 |
| 13 | TESK2 | 2.44304489 |
| 14 | TNK2 | 2.35239715 |
| 15 | DAPK1 | 2.29720267 |
| 16 | FES | 2.22041225 |
| 17 | BMX | 2.19673224 |
| 18 | TRPM7 | 2.12057885 |
| 19 | TYRO3 | 2.11911323 |
| 20 | PRKD2 | 2.04704714 |
| 21 | TGFBR2 | 2.03683478 |
| 22 | UHMK1 | 2.00857363 |
| 23 | SYK | 1.86850460 |
| 24 | DYRK1B | 1.86061359 |
| 25 | MAP4K2 | 1.83112807 |
| 26 | CSF1R | 1.82471863 |
| 27 | MAP2K3 | 1.73736347 |
| 28 | PIM1 | 1.65899979 |
| 29 | CDK7 | 1.58984342 |
| 30 | MAP3K3 | 1.54826424 |
| 31 | ACVR1B | 1.54044657 |
| 32 | GRK6 | 1.48666028 |
| 33 | AKT3 | 1.45026050 |
| 34 | RPS6KC1 | 1.44234571 |
| 35 | RPS6KL1 | 1.44234571 |
| 36 | PDGFRA | 1.41366654 |
| 37 | ADRBK2 | 1.37413706 |
| 38 | FRK | 1.34365652 |
| 39 | RPS6KA6 | 1.33273943 |
| 40 | KDR | 1.32620180 |
| 41 | CDK6 | 1.27892655 |
| 42 | ITK | 1.23473640 |
| 43 | MAPK11 | 1.23332165 |
| 44 | GRK7 | 1.19383115 |
| 45 | MST4 | 1.18117009 |
| 46 | HCK | 1.15270342 |
| 47 | GSK3A | 1.09931833 |
| 48 | MARK3 | 1.09781137 |
| 49 | PIK3CG | 1.05120264 |
| 50 | DYRK3 | 1.04286457 |
| 51 | CAMKK2 | 1.02576571 |
| 52 | PRPF4B | 0.95452146 |
| 53 | IKBKB | 0.94308479 |
| 54 | ABL2 | 0.92838177 |
| 55 | LYN | 0.85292926 |
| 56 | BCKDK | 0.83544377 |
| 57 | VRK2 | 0.83350722 |
| 58 | BMPR2 | 0.81651728 |
| 59 | CHEK2 | 0.80858497 |
| 60 | NUAK1 | 0.80048565 |
| 61 | TESK1 | 0.79179635 |
| 62 | MAP3K13 | 0.78691546 |
| 63 | ERN1 | 0.78490038 |
| 64 | HIPK2 | 0.78232453 |
| 65 | CDC42BPA | 0.77665927 |
| 66 | JAK1 | 0.76474970 |
| 67 | IRAK1 | 0.76111851 |
| 68 | PRKCQ | 0.75851469 |
| 69 | TLK1 | 0.73987757 |
| 70 | NEK9 | 0.72513122 |
| 71 | MAP3K10 | 0.69839574 |
| 72 | TGFBR1 | 0.69089642 |
| 73 | TAOK2 | 0.68768120 |
| 74 | MAP3K14 | 0.67345815 |
| 75 | TBK1 | 0.67300157 |
| 76 | MAP4K1 | 0.67085476 |
| 77 | MAP2K6 | 0.64101395 |
| 78 | SIK3 | 0.63420980 |
| 79 | PLK1 | 0.62730008 |
| 80 | MAP3K1 | 0.62546516 |
| 81 | TYK2 | 0.61640809 |
| 82 | RPS6KB2 | 0.61473635 |
| 83 | BLK | 0.60831758 |
| 84 | PHKG2 | 0.60414078 |
| 85 | PHKG1 | 0.60414078 |
| 86 | MAP2K2 | 0.60032637 |
| 87 | FLT3 | 0.59598856 |
| 88 | ADRBK1 | 0.59147469 |
| 89 | RPS6KA1 | 0.58910771 |
| 90 | TAOK1 | 0.57943906 |
| 91 | ERBB3 | 0.56379667 |
| 92 | ATR | 0.55669892 |
| 93 | PTK2B | 0.53900832 |
| 94 | CDK19 | 0.53459050 |
| 95 | EPHA2 | 0.52143395 |
| 96 | EGFR | 0.51514861 |
| 97 | GRK1 | 0.50666263 |
| 98 | DAPK2 | 0.50361184 |
| 99 | IRAK4 | 0.48438124 |
| 100 | CAMK2G | 0.47929245 |
| 101 | CHUK | 0.47523832 |
| 102 | CSNK2A1 | 0.46865846 |
| 103 | LCK | 0.46191123 |
| 104 | RAF1 | 0.45523366 |
| 105 | MAPK3 | 0.45462701 |
| 106 | LRRK2 | 0.45116548 |
| 107 | PRKAA1 | 0.44851745 |
| 108 | DYRK2 | 0.44808845 |
| 109 | TAOK3 | 0.43683209 |
| 110 | MTOR | 0.43612644 |
| 111 | IRAK3 | 0.43504366 |
| 112 | LIMK1 | 0.42693913 |
| 113 | OXSR1 | 0.42583155 |
| 114 | PDK1 | 0.42177532 |
| 115 | PBK | 0.41166296 |
| 116 | RPS6KB1 | 0.39983478 |
| 117 | MAPK7 | 0.39554848 |
| 118 | EPHB1 | 0.38709836 |
| 119 | MAPK4 | 0.38032157 |
| 120 | IKBKE | 0.37580759 |
| 121 | MAPKAPK2 | 0.36924874 |
| 122 | KIT | 0.36883593 |
| 123 | LATS2 | 0.36879223 |
| 124 | ZAP70 | 0.36022539 |
| 125 | ARAF | 0.34804018 |
| 126 | PRKCD | 0.34542815 |
| 127 | PRKAA2 | 0.34362104 |
| 128 | NME2 | 0.34034534 |
| 129 | CSNK1G1 | 0.33922849 |
| 130 | PRKCI | 0.33855332 |
| 131 | MAP3K5 | 0.33691665 |
| 132 | MAPK1 | 0.33352952 |
| 133 | ABL1 | 0.33114926 |
| 134 | INSRR | 0.31692548 |
| 135 | PDPK1 | 0.31686958 |
| 136 | ZAK | 0.30985761 |
| 137 | CAMK2B | 0.30238207 |
| 138 | MAP2K1 | 0.29538683 |
| 139 | VRK1 | 0.29099539 |
| 140 | BTK | 0.28992699 |
| 141 | PRKD1 | 0.28039162 |
| 142 | STK3 | 0.28032381 |
| 143 | CDK2 | 0.24360617 |
| 144 | JAK3 | 0.23512770 |
| 145 | MAPKAPK3 | 0.23443230 |
| 146 | STK4 | 0.21231670 |
| 147 | CSNK2A2 | 0.20885052 |
| 148 | BUB1 | 0.20448000 |
| 149 | CAMK2D | 0.20107351 |
| 150 | MUSK | 0.19148734 |
| 151 | TXK | 0.18340453 |
| 152 | INSR | 0.17932242 |
| 153 | PDGFRB | 0.17354436 |
| 154 | STK10 | 0.17192453 |
| 155 | JAK2 | 0.17155597 |
| 156 | MAPK14 | 0.16052312 |
| 157 | TEC | 0.14237537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.51908186 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 4.31425558 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.24995371 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.28835654 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.97697213 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.91430726 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72217761 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64530638 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.48956426 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.39616001 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.36123945 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34849169 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.31781934 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30431524 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.16913351 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.13059043 |
| 17 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.10305606 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.03283257 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02661163 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01564460 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.96720110 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.87345897 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.85884048 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77625940 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71159077 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68020836 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.65433869 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55855275 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52154173 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51621939 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.47486170 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45968766 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45088675 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.44993423 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.43318482 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.41480656 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.40493966 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36340867 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35999541 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34888730 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.34296698 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30806901 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.28245316 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.28234812 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27885153 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.22269819 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21738836 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19548550 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.18501390 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16846860 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15541519 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15461545 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15315753 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.15122321 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11639955 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10989782 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08406685 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03341411 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98422461 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97766826 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 0.95884188 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95595810 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93030392 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92955068 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91441546 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90948012 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.88958909 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88601032 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84469064 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.84060826 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.82415597 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82362714 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80931316 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80892511 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.80429364 |
| 76 | Ribosome_Homo sapiens_hsa03010 | 0.78706603 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78588320 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77838516 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76885372 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.74007883 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73859578 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73734827 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73460037 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71925998 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71884393 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.71626648 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.71469496 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70869318 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.70831857 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.69346917 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67748586 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.67694723 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67182321 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65054291 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.63752561 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61243067 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61043344 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60904525 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60596966 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.60432081 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.56859928 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.56812977 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55733536 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55436880 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55130613 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53872914 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53263778 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53024347 |
| 109 | RNA polymerase_Homo sapiens_hsa03020 | 0.51889348 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51705870 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51396242 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50494385 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50428884 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50373772 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49638203 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49620199 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48124889 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48001571 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46860933 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.46244702 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.45076944 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44624528 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43339696 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42248465 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42059750 |
| 126 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41870752 |
| 127 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41801696 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41764599 |
| 129 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41089054 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39681362 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38097219 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36658007 |
| 133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35349984 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35322602 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35268666 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35267777 |
| 137 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34449345 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33417063 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33050991 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.32144153 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31366069 |
| 142 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28419134 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28346884 |
| 144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28151606 |
| 145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28001266 |
| 146 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27780669 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27778412 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27766814 |
| 149 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27668314 |
| 150 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27526621 |
| 151 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27492683 |
| 152 | Endocytosis_Homo sapiens_hsa04144 | 0.25406316 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24534416 |
| 154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24235560 |
| 155 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24128144 |
| 156 | Phototransduction_Homo sapiens_hsa04744 | 0.23759189 |

